newsInvesting $300mn, Novartis aims to support the growth and diversity…
12 September 2022 | By Hannah Balfour (European Pharmaceutical Review)
Investing $300mn, Novartis aims to support the growth and diversity of its biotherapeutics portfolio with technical capabilities to expedite early development.